Status:
COMPLETED
Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia
Lead Sponsor:
Ente Ospedaliero Ospedali Galliera
Conditions:
Thalassemia Major
Thalassemia Intermedia
Eligibility:
All Genders
18-80 years
Brief Summary
This is a multicenter observational case-control analysis lasting 12 months aimed at determining the prevalence of pulmonary hypertension (PAH) in patients with Thalassemia Major and Intermedia. The p...
Detailed Description
The most recent International Classification of pulmonary arterial hypertension (PHA) include Hemoglobinopathies in Class I. At present there is no determination of the prevalence of this disease in a...
Eligibility Criteria
Inclusion
- Patients with Thalassemia Major Patients or Intermediate referring to Centres using Web-Thal medical record (a clinical data sheet used for congenital anemias. Info: www.thalassemia.it)
Exclusion
- Patients who are considered potentially unreliable and/or not cooperative
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT01496963
Start Date
January 1 2012
End Date
December 1 2021
Last Update
August 4 2022
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
SCDU Microcitemie-Pediatria A.O. Universitaria S.Luigi Gonzaga di Orbassano
Orbassano, Turin, Italy, 10043
2
Divisione di Ematologia Ospedale Perrino
Brindisi, Italy, 72100
3
Clinica pediatrica Ospedale Microcitemico
Cagliari, Italy, 09123
4
DH Microcitemia dell'adulto Ospedale Microcitemico
Cagliari, Italy, 09123